Company Cyteir Therapeutics, Inc.
Equities
CYTT
US23284P1030
Biotechnology & Medical Research
Business Summary
Number of employees: 46
Managers
Managers | Title | Age | Since |
---|---|---|---|
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/16/01 |
David Gaiero
DFI | Director of Finance/CFO | 45 | 01/20/01 |
Susan Doleman
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Judson Englert
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
General Counsel | - | 03/22/03 | |
Gale Cohen
HRO | Human Resources Officer | - | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Thero
BRD | Director/Board Member | 63 | 04/22/04 |
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/16/01 |
Jean George
BRD | Director/Board Member | 66 | 01/13/01 |
Chairman | 60 | 01/18/01 | |
Stephen Sands
BRD | Director/Board Member | 67 | 22/22/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,005,401 | 33,493,836 ( 93.02 %) | 7,333 ( 0.0204 %) | 93.02 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |